Article
Daewoong And Celltrion To Market Denosumab Biosimilar In Korea
Daewoong Pharmaceutical announced on October 31 that it has signed a joint sales agreement with Celltrion Pharm to market CT-P41 in Korea. CT-P41, Celltrion's biosimilar of Amgen's PROLIA...
Goodwin Procter LLP